 |
Xi'an Libang Pharmaceutical Co., Ltd.
Xi'an, Shaanxi 710075
China
Tel: 86-29-89527363
Fax: 86-29-89527363
Website: https://www.libangpharma.com/
Contact: Mr. Jimmy Tian, Head of International Business
| Email: |  |
| Type of Business: | Manufacturer, Exporter |
| Year Established: | 1996 |
| Harmonized System Codes: | 0801 1001 1701 2101 SC58 |
Business Message
XI’AN LIBANG PHARMACEUTICAL CO.,LTD. was founded in 1996 with the location at Xi’an of China, the center of the northwest pharmaceutical industry,
specialized in research, development, production and distribution of generic Finished Dosage Forms and high-valued APIs. With two decades of rapid growth, LIBANG has transformed into an integrated healthcare solution provider with diversified fields covering prescription drugs, OTC products, APIs, pharmaceutical excipients, medical devices that bring in more than US$400 million in annual revenue. LIBANG has been rated as the Top 100 China’s Pharmaceutical Industries for successive years and also listed in the Top 20 The Most Potential Chinese Pharmaceuticals issued by the IMS Health.
Science and technology constitute the primary productive force. Researching is the engine of healthcare industries. Libang has built an excellent R&D team, possessing three R&D entities: Lipont Pharmaceutical Inc Canada, Xi’anLibang-Zhaoxin Bio-tech Inc and Xi’an Libang Medi-tech Inc. 8% to 10% of annual sale revenues is devoted to R&D. Based on the domestic and Canadian R&D centers, Libang also networks with experts from leading research institutes at home and abroad, such as Tsinghua University, Northwestern University, University of British Columbia, Canada, established close technical cooperation relationship with several research institutions in
the United States. Broad academic thoughts, strong scientific research advantages and high-end technical supports ensure Libang’s sustainable development.
LIBANG owns 3 FDF facilities and 3 APIs plants, all of them are operated in strict conformity to GMP.
Xi’an Formulation Plant is located in the Xi`an Hi-Tech Zone, renovated in 2013, has passed CFDA inspection and obtained the national GMP certificate.
There are three Small Volume Parenterals production lines dedicated for lipid injectable emulsion: two for ampoules, one for vials.
SVP Annual Production Capacities: 70 million amps/vials
Baoji Formulation Plant is located in Baoji city, Shaanxi Province, dedicated for Large Volume Parenterals production, obtained the GMP certificate in 2010.
LVP Annual Production Capacities: 8 million bottles
Hanfeng Formulation Plant is a newly GMP facilities built in 2011, equipped with Class B+A Clean Area, has 3 Small Volume injection production lines with annual production capacity of 300 million ampoules and 2 solid dosage production with annual production capacity at 900 million tablets and 240
million capsules.
Xi’an API Plant is built in 1996, occupies 10000 square meters, with workshop area of 400 square meters and clean room area of 240 square meters. The plant is constructed and managed in full compliance with international recognized cGMP, has been successfully inspected and approved by US FDA
for 3 times.
Baoji API Plant is established in 2003, occupies 40680 square meters，with 4 workshops, 756 square meters clean area, has 100 tons annual product
capacity.
Shenyang API Plant is established in 2017, occupies 70000 square meters, with 3 workshops, the annual product capacity is around 20000kgs.
Xi'an Libang Pharmaceutical Co., Ltd. is a professional Manufacture specializing in pharmaceutical raw materials and Finished dosage form. The company has gathered a dedicated and professional sales and technical personnel. We have a marketing team with first-class efficiency and first-class service! Strong technical force, high quality and low price products, first-class marketing and after-sales service are your best choice!
 White Powder Diatrizoic Acid USP Amidotrizoic Acid Dihydate | ||||
